What autoimmune process characterizes myasthenia gravis?

• A. Destruction of motor neurons
• B. Production of antibodies against acetylcholine receptors
• C. Overproduction of neurotransmitters
• D. Inhibition of nerve growth factor

Answer: (B)

Myasthenia gravis is characterized by the production of antibodies against acetylcholine receptors at the neuromuscular junction. This autoimmune process disrupts the communication between nerves and muscles, leading to muscle weakness and fatigue. In a healthy system, acetylcholine is released from nerve endings and binds to acetylcholine receptors on muscle cells, triggering muscle contraction. However, in myasthenia gravis, the body's immune system mistakenly targets these receptors, preventing the normal action of acetylcholine. As a result, muscle fibers receive insufficient stimulation, leading to the hallmark symptoms of the condition.

The other options do not accurately describe the underlying mechanism of myasthenia gravis. For example, destruction of motor neurons is characteristic of diseases like amyotrophic lateral sclerosis, while overproduction of neurotransmitters is not a feature of myasthenia gravis. Similarly, inhibition of nerve growth factor pertains to other neurological conditions and does not relate to the primary dysfunction in myasthenia gravis. Understanding this autoimmune response is crucial for diagnosing, managing, and treating the condition effectively.